Boris Keweloh, CryoVasc - Renal Cryo Denervation | LSI Europe '24

Cryovasc is the first to apply low-risk but highly effective cryoablation technology for catheter-based renal denervation to treat arterial hypertension.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Boris Keweloh
Boris Keweloh
CEO, Cryovasc